ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

ClinicalTrials.gov ID: NCT00327691

Public ClinicalTrials.gov record NCT00327691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD

Study identification

NCT ID
NCT00327691
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
8,600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 1998
Primary completion
Not listed
Completion
Jul 31, 2004
Last update posted
May 2, 2007

1998 – 2004

United States locations

U.S. sites
181
U.S. states
40
U.S. cities
132
Facility City State ZIP Site status
Pfizer Investigational Site Alabaster Alabama 35007
Pfizer Investigational Site Birmingham Alabama 35205-4785
Pfizer Investigational Site Birmingham Alabama 35213
Pfizer Investigational Site Birmingham Alabama 35294-2041
Pfizer Investigational Site Hoover Alabama 35216
Pfizer Investigational Site Montgomery Alabama 36117
Pfizer Investigational Site Mesa Arizona 85202
Pfizer Investigational Site Mesa Arizona 85206
Pfizer Investigational Site Burbank California 91505
Pfizer Investigational Site Camp Pendleton California 92055
Pfizer Investigational Site Fresno California 93703
Pfizer Investigational Site La Jolla California 92037
Pfizer Investigational Site Loma Linda California 92354
Pfizer Investigational Site Los Angeles California 90017-2395
Pfizer Investigational Site Los Angeles California 90048
Pfizer Investigational Site Modesto California 95350
Pfizer Investigational Site Pasadena California 91105
Pfizer Investigational Site Rancho Mirage California 92270
Pfizer Investigational Site San Diego California 92134-3303
Pfizer Investigational Site San Francisco California 94143-0130
Pfizer Investigational Site San Francisco California 94143-0326
Pfizer Investigational Site Santa Rosa California 95403
Pfizer Investigational Site Stanford California
Pfizer Investigational Site Aurora Colorado 80012
Pfizer Investigational Site Denver Colorado 80203
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Denver Colorado 80220
Pfizer Investigational Site Bridgeport Connecticut 06610
Pfizer Investigational Site Hartford Connecticut 06102
Pfizer Investigational Site New Britain Connecticut 06053
Pfizer Investigational Site Newark Delaware 19718
Pfizer Investigational Site Washington D.C. District of Columbia 20037
Pfizer Investigational Site Clearwater Florida 33756
Pfizer Investigational Site Gainsville Florida 32608
Pfizer Investigational Site Gainsville Florida 32610
Pfizer Investigational Site Hollywood Florida 33021
Pfizer Investigational Site Inverness Florida 34452
Pfizer Investigational Site Lakeland Florida 33805
Pfizer Investigational Site Miami Florida 33173
Pfizer Investigational Site Miami Florida 33176
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Orlando Florida 32803
Pfizer Investigational Site Port Charlotte Florida 33952
Pfizer Investigational Site Sarasota Florida 34239
Pfizer Investigational Site Stuart Florida 34996
Pfizer Investigational Site Tamarac Florida 33321
Pfizer Investigational Site The Villages Florida 32159
Pfizer Investigational Site Atlanta Georgia 30309
Pfizer Investigational Site Canton Georgia 30114
Pfizer Investigational Site Berwyn Illinois 60402
Pfizer Investigational Site Blue Island Illinois 60406
Pfizer Investigational Site Chicago Illinois 60610
Pfizer Investigational Site Chicago Illinois 60611
Pfizer Investigational Site Du Quoin Illinois 62832
Pfizer Investigational Site Evanston Illinois 60201
Pfizer Investigational Site Lake Forest Illinois 60045
Pfizer Investigational Site Marion Illinois 62959
Pfizer Investigational Site Pekin Illinois 61554
Pfizer Investigational Site Peoria Illinois 61603
Pfizer Investigational Site Peoria Illinois 61614
Pfizer Investigational Site Beech Grove Indiana 46107
Pfizer Investigational Site Evansville Indiana 47710
Pfizer Investigational Site Fort Wayne Indiana 46805
Pfizer Investigational Site Fort Wayne Indiana 46825
Pfizer Investigational Site Jeffersonville Indiana 47130
Pfizer Investigational Site Scottsburg Indiana 47170
Pfizer Investigational Site Des Moines Iowa 50314
Pfizer Investigational Site Iowa City Iowa 52242
Pfizer Investigational Site Kansas City Kansas 66160-7200
Pfizer Investigational Site Lathe Kansas 66061
Pfizer Investigational Site Overland Park Kansas 66213
Pfizer Investigational Site Wichita Kansas 67220
Pfizer Investigational Site Edgewood Kentucky 41017
Pfizer Investigational Site Erlanger Kentucky 41018
Pfizer Investigational Site Louisville Kentucky 40202
Pfizer Investigational Site Marrero Louisiana 70072
Pfizer Investigational Site New Orleans Louisiana 70112
Pfizer Investigational Site New Orleans Louisiana 70121
Pfizer Investigational Site Portland Maine 04102
Pfizer Investigational Site Baltimore Maryland 21201
Pfizer Investigational Site Baltimore Maryland 21204
Pfizer Investigational Site Baltimore Maryland 21205
Pfizer Investigational Site Baltimore Maryland 21208
Pfizer Investigational Site Baltimore Maryland 21218
Pfizer Investigational Site Baltimore Maryland 21224
Pfizer Investigational Site Baltimore Maryland 21228
Pfizer Investigational Site Baltimore Maryland 21229
Pfizer Investigational Site Baltimore Maryland 21237
Pfizer Investigational Site Baltimore Maryland 21287
Pfizer Investigational Site Bel Air Maryland 21014
Pfizer Investigational Site Westminster Maryland 21157
Pfizer Investigational Site Boston Massachusetts 02111
Pfizer Investigational Site Boston Massachusetts 02215
Pfizer Investigational Site Burlington Massachusetts 1805
Pfizer Investigational Site Dearborn Michigan 48126
Pfizer Investigational Site Detroit Michigan 48202
Pfizer Investigational Site Farmington Hill Michigan 48336
Pfizer Investigational Site Sterling Heights Michigan 48310
Pfizer Investigational Site West Bloomfield Michigan 48322
Pfizer Investigational Site Duluth Minnesota 55805
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Maplewood Minnesota 55109
Pfizer Investigational Site Minneapolis Minnesota 55455
Pfizer Investigational Site Saint Paul Minnesota 55102
Pfizer Investigational Site Kansas City Missouri 64111
Pfizer Investigational Site St Louis Missouri 63104
Pfizer Investigational Site St Louis Missouri 63110-0205
Pfizer Investigational Site St Louis Missouri 63110
Pfizer Investigational Site St Louis Missouri 63117
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Papillion Nebraska 68046
Pfizer Investigational Site Manchester New Hampshire 03102
Pfizer Investigational Site New Brunswick New Jersey 08901
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Brooklyn New York 11203
Pfizer Investigational Site Hawthorne New York 10535
Pfizer Investigational Site Manlius New York 13104
Pfizer Investigational Site New York New York 10021
Pfizer Investigational Site New York New York 10029
Pfizer Investigational Site New York New York 10032
Pfizer Investigational Site Rochester New York 14607
Pfizer Investigational Site Rochester New York 14618
Pfizer Investigational Site Rochester New York 14621
Pfizer Investigational Site Syracuse New York 13202
Pfizer Investigational Site Syracuse New York 13210
Pfizer Investigational Site Valhalla New York 10595
Pfizer Investigational Site Asheville North Carolina 28803
Pfizer Investigational Site Durham North Carolina 27710
Pfizer Investigational Site Eden North Carolina 27288
Pfizer Investigational Site Winston-Salem North Carolina 27157
Pfizer Investigational Site Beachwood Ohio 44122
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45229
Pfizer Investigational Site Cincinnati Ohio 45246
Pfizer Investigational Site Cleveland Ohio 44106-5038
Pfizer Investigational Site Cleveland Ohio 44195
Pfizer Investigational Site Columbus Ohio 43210
Pfizer Investigational Site Columbus Ohio 43221
Pfizer Investigational Site Kettering Ohio 45429-1221
Pfizer Investigational Site Lorain Ohio 44053
Pfizer Investigational Site Sandusky Ohio 44870
Pfizer Investigational Site Oklahoma City Oklahoma 73104
Pfizer Investigational Site Tulsa Oklahoma 74133
Pfizer Investigational Site Tulsa Oklahoma 74136-1920
Pfizer Investigational Site Tulsa Oklahoma 74136
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Portland Oregon 97216
Pfizer Investigational Site Allentown Pennsylvania 18102
Pfizer Investigational Site Allentown Pennsylvania 18106-0880
Pfizer Investigational Site Lansdale Pennsylvania 19446
Pfizer Investigational Site Lehighton Pennsylvania 18235
Pfizer Investigational Site Philadelphia Pennsylvania 19104
Pfizer Investigational Site Philadelphia Pennsylvania 19107
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Sellersville Pennsylvania 18960
Pfizer Investigational Site Pawtucket Rhode Island 02860
Pfizer Investigational Site Providence Rhode Island 02906
Pfizer Investigational Site Charleston South Carolina 29403
Pfizer Investigational Site Sioux Falls South Dakota 57105
Pfizer Investigational Site Sioux Falls South Dakota 57108
Pfizer Investigational Site Memphis Tennessee 38104
Pfizer Investigational Site Memphis Tennessee 38105
Pfizer Investigational Site Memphis Tennessee 38119-5209
Pfizer Investigational Site Memphis Tennessee 38128
Pfizer Investigational Site Nashville Tennessee 37205
Pfizer Investigational Site Nashville Tennessee 37232-6300
Pfizer Investigational Site Austin Texas 78756
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Dallas Texas 75390-9047
Pfizer Investigational Site Denton Texas 76204
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Lackland Air Force Base Texas 78236-5300
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Salt Lake City Utah 84124
Pfizer Investigational Site Burlington Vermont 05401
Pfizer Investigational Site Richmond Virginia 23249
Pfizer Investigational Site Richmond Virginia 23298
Pfizer Investigational Site Seattle Washington 98104
Pfizer Investigational Site Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00327691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2007 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00327691 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →